Treatment
Blood samples clinical trials
We’re tracking 699 recruiting studies that include Blood samples, each written for real people, not researchers, below.
Recruiting studies
- NCT06474182Recruiting
Apixaban for blood clots in myeloma patients
This study looks at how Apixaban (a blood thinner) works in people with newly diagnosed multiple myeloma. It compares them to people having knee replacement surgery. The goal is to see if the drug prevents clots effectively in both groups.
Saint-EtienneAges 18 years+ - NCT06474169Recruiting
T-cell study in long-term kidney failure
This study is looking at how immune cells called T-cells work in people with long-term kidney failure. It tests whether these cells can be changed in the lab to help treat the condition.
OrléansAges 18 years+ - NCT06475469Recruiting
Immune system in untreated CLL and infection risk
This study looks at how the immune system works in people with untreated CLL and tries to find ways to predict who might get infections. It aims to help doctors better protect patients from infections in the future.
ReimsAges 18 years+ - NCT06479070Recruiting
Using ctDNA to guide radiotherapy for head and neck cancer
This study looks at whether measuring a DNA fragment in the blood (called ctDNA) can help predict how well radiotherapy works for head and neck cancer. It may help doctors better tailor treatment for patients with stage III or IV disease.
Caen, CaenAges 18 years+ - NCT07178847Recruiting
Cancer DNA after chemoradiation for head and neck cancer
This study looks for cancer DNA left in the body after standard chemoradiation for advanced head and neck squamous cell cancer. It aims to understand if this residual DNA means the disease is more likely to come back.
Aurillac, CANTALAges 18–80 - NCT07692815Enrolling by invitation
Sex differences in response to strength training
This study looks at how men and women respond differently to resistance (strength) exercise. It may help you understand how your body adapts to training based on your sex.
Louvain-la-NeuveAges 18–40 - NCT06519942Recruiting
Muscle and bone health in diabetes with nerve damage
This study looks at how diabetes and nerve damage affect your muscles and bones. It compares people with type 2 diabetes to healthy volunteers to learn more about these changes.
GhentAges 40–70 - NCT06528171Recruiting
Long COVID immunity and imaging study
This trial studies people who had COVID-19 to understand why some develop long-term symptoms while others recover fully. It aims to find links between the immune system and brain changes using imaging.
NiceAges 18 years+ - NCT06536127Recruiting
Immune cells in non-spreading rectal cancer treatment
This study is looking at immune cells (NK cells and ImmunoScore) in the blood of people with rectal cancer that hasn't spread. It may help doctors learn more about how the immune system responds to standard chemoradiation treatment.
AvignonAges 18 years+ - NCT06549374Recruiting
Infection risk test in intensive care patients
This study looks at how the body's immune system responds to severe injury or illness by measuring a substance called interferon-gamma (IFN-γ) in the blood. The goal is to better understand infection risk and help doctors improve care for patients in the intensive care unit (ICU).
AnnecyAges 18 years+ - NCT06555120Recruiting
Screening kids for inherited high cholesterol
This study checks children for a genetic condition that causes very high cholesterol from a young age. If found early, steps can be taken to lower heart disease risk later in life.
AmiensAges 2–18 - NCT06555757Recruiting
Using AI and sound to predict heart failure worsening
This trial uses a smartphone app to record sounds from your chest and breathing. An AI system will analyze these sound patterns to predict when heart failure symptoms might get worse, so you can get help sooner.
Cambridge, CambridgeshireAges 18 years+ - NCT06572735Recruiting
PARP Inhibitor Dosing in Older Ovarian Cancer Patients
This trial studies how well older adults (70+) with advanced ovarian cancer tolerate PARP inhibitors in real-world care. It aims to see if the standard dose works for this age group.
AmiensAges 70 years+ - NCT06580418Recruiting
Study of an anti-TREM-1 drug in a gut model
This trial tests a new drug that blocks a protein called TREM-1, which may help reduce inflammation in the gut. It uses tissue samples from people with active ulcerative colitis or Crohn's disease to see if the drug is effective.
MilanAges 18–60 - NCT06582199Recruiting
Personalized Alzheimer's study using brain scans and spinal fluid
This study looks at how to better predict and understand Alzheimer's disease by using advanced brain scans and spinal fluid tests. It aims to find ways to identify people who stay healthy longer despite risk factors.
ParisAges 50–90 - NCT06587828Recruiting
Looking at immune cells in people with autoimmune disease
This study collects blood, tissue, and other samples from people with autoimmune diseases like Crohn's disease, multiple sclerosis, or lupus. Researchers will study your immune cells (T cells) to learn what they are attacking, which could lead to better treatments in the future.
Orange, CaliforniaAges 18 years+ - NCT06601998Recruiting
Heart health after severe pneumonia
This study looks at how heart health changes in people who have recovered from severe pneumonia, including COVID-19. It compares survivors to healthy people and those with heart risk factors.
AlexandroupoliAges 18 years+ - NCT06603506Recruiting
Testing PARP inhibitors on your endometrial cancer cells
This study is testing whether a special kind of medicine called a PARP inhibitor can work against endometrial cancer cells grown in a lab from your tumor. The goal is to find out which patients might benefit from this treatment in the future.
CaenAges 18 years+ - NCT06608849Recruiting
Long-term health effects after COVID-19
This study looks at how COVID-19 may affect the lungs, heart, and kidneys in the months or years after the infection. It compares three groups: people who never had COVID, people who had COVID but recovered without organ problems, and people who had organ problems during COVID. The goal is to understand what long-term complications might arise.
AthensAges 18 years+ - NCT06609668Recruiting
Thrombomodulin blood test to rule out giant cell arteritis in PMR
This study tests whether a blood test for a protein called thrombomodulin can help rule out giant cell arteritis (a blood vessel inflammation) in people with polymyalgia rheumatica. It involves a blood draw and a one-time imaging scan to look at your blood vessels.
DijonAges 50 years+ - NCT06610851Recruiting
Monitoring low-grade brain tumors with a blood test
This study is looking at whether a simple blood test that checks for tiny molecules (called miRNAs) can help monitor people with slow-growing brain tumors. If you had surgery for a grade 2 or 3 glioma at Caen University Hospital and are still being followed there, this study might be for you.
CaenAges 18 years+ - NCT06618989Recruiting
Predicting serious bacterial infection in febrile infants
This trial is testing a new blood test to help doctors tell which babies under three months with fever are at risk for a serious bacterial infection. If successful, it could help avoid unnecessary antibiotics and hospital stays.
Paris, FranceAges 1 week–3 months - NCT06626269Recruiting
Biomarkers for immunotherapy in digestive and gynecological cancers
This study looks for new markers in the blood or tumor that could predict how well immunotherapies work for advanced digestive and gynecological cancers. It includes people getting immunotherapy, chemotherapy, or targeted therapy, and also those with certain liver or abdominal metastases that can be surgically removed after chemo.
BesançonAges 18 years+ - NCT06636318Recruiting
Immune changes during 24-hour surgery call
This study looks at how being on call for 24 hours affects the immune system of surgery residents. The goal is to see if these long shifts change how the body fights infection.
Chicago, IllinoisAges 18 years+
Common questions
- Are there clinical trials studying Blood samples?
- Yes. Clin2 currently lists 699 recruiting studies that include Blood samples, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Blood samples trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Blood samples an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Blood samples or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.